- Home
- PHM vs BNTX Comparison
PHM vs BNTX Comparison
Compare PHM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHM | BNTX |
|---|---|---|
| Founded | 1950 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.7B | 25.5B |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PHM | BNTX |
|---|---|---|
| Price | $119.19 | $91.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 13 |
| Target Price | ★ $137.67 | $134.15 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 11.12 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.05 | $2.61 |
| P/E Ratio | $10.81 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $88.07 | $79.81 |
| 52 Week High | $144.50 | $124.00 |
Technical Indicators
Market Signals| Indicator | PHM | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 28.09 | 35.49 |
| Support Level | $118.61 | N/A |
| Resistance Level | $122.27 | $112.30 |
| Average True Range (ATR) | 3.67 | 3.29 |
| MACD | -2.12 | -1.97 |
| Stochastic Oscillator | 0.04 | 34.40 |
Price Performance
Historical ComparisonAbout PHM PulteGroup Inc.
PulteGroup Inc is a homebuilder in the United States. The company mainly builds single-family detached homes and offers products to entry-level, move-up, and active-adult buyers. It also offers homebuyers mortgage financing, title, and insurance agency services through its financial services segment.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.